BCM
RVLP

Bridgeway Capital Management’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Bridgeway Capital Management’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-31,500
Closed -$35.9K – 1471
2023
Q1 		$35.9K Hold
31,500
– – ﹤0.01% 1340
2022
Q4 		$35.3K Buy
+31,500
New +$50.2K ﹤0.01% 1322

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridgeway Capital Management's RVLP Position: Q2 2023 in Review

Bridgeway Capital Management sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q2 2023, closing a stake of 31,500 shares — an estimated $35.9K sold.

Bridgeway Capital Management first reported a position in RVLP in Q4 2022 and held it in 2 quarters. The position peaked at $35.9K in Q1 2023. 36 funds tracked by Wall St. Rank hold RVLP as of Q2 2023.

  • Bridgeway Capital Management reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q2 2023 after selling out during the quarter.
  • Bridgeway Capital Management sold 31,500 RVL Pharmaceuticals plc Ordinary Shares shares in Q2 2023, an estimated $35.9K.
  • Bridgeway Capital Management first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2022 and held it in 2 quarters.
  • Bridgeway Capital Management's RVL Pharmaceuticals plc Ordinary Shares position peaked at $35.9K in Q1 2023.
  • 36 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q2 2023.

Based on Bridgeway Capital Management's 13F filing for Q2 2023, filed 14 Aug 2023.